9621 Agnes Crossing, Lake Suzanneview, New Mexico Island 84604-9295.
If you’re tracking revenue cycle management news, the short version for 2026 is this: automation has moved from a nice-to-have to the default expectation, denial rates are still
If you’re tracking revenue cycle management news, the short version for 2026 is this: automation has moved from a nice-to-have to the default expectation, denial rates are still rising for many US health systems, and AI tools are now handling tasks that used to sit firmly with human billing staff. This is a US-centric topic, since revenue cycle management describes the insurance-based billing process that runs from patient registration through to final payment, a system that doesn’t map onto the NHS the same way.
That said, plenty of UK-based readers have good reason to follow this closely: health-tech vendors selling into the US market, outsourcing and BPO firms handling back-office billing work for American clients, and investors watching a sector that’s grown substantially on the back of automation spending. This roundup covers what’s actually changed recently, what robotic process automation (RPA) is doing inside revenue cycle teams right now, and where to go for reliable, current coverage.
Revenue cycle management, usually shortened to RCM in industry coverage, is the process used by healthcare systems, mainly in the United States, to track revenue from a patient’s initial appointment through to final payment of any balance owed. It typically spans patient registration, insurance verification, charge capture, medical coding, claim submission, payment posting, and accounts receivable follow-up.
Every one of those stages can go wrong in ways that cost a hospital real money. Errors in revenue cycle management can lead to delayed payments or no payment at all, which is exactly why so much recent revenue cycle management news centres on automation and AI, since both promise to catch and prevent those errors before they hit a hospital’s books.
A few clear themes run through current coverage from trade press like Becker’s Hospital Review, HFMA and Healthcare Finance News.
The US healthcare industry avoided an estimated $258 billion in unnecessary administrative spending through automation and electronic transactions in 2024 alone, according to industry figures cited by automation vendors, though that figure comes from the sector itself rather than an independent audit, so treat it as directional rather than exact. What’s clearer is the direction of travel: some industry voices now expect the majority of revenue cycle management to eventually be handled by an AI agent rather than human staff performing each step manually.
Prior authorisation has become one of healthcare’s most expensive administrative bottlenecks, slowing patient access, adding labour-intensive work, increasing denial risk, and putting pressure on reimbursement and cash flow across hospitals and health systems. This is a recurring theme across nearly every major trade publication currently covering RCM, and it’s one of the clearest examples of a process ripe for automation, since much of the back-and-forth between provider and payer follows predictable, rules-based steps.
Trade press coverage in mid-2026 has tracked a steady stream of leadership changes and structural shifts across the sector. Recent coverage has included stories on health systems dropping Medicare Advantage plans, hospitals naming new revenue cycle vice presidents, and questions over where automation still can’t beat the human touch in the revenue cycle. That last point matters for anyone evaluating vendor claims: even enthusiastic automation coverage tends to acknowledge that judgement-heavy tasks, like complex denial appeals, still benefit from experienced staff.
This is the technical core of most current revenue cycle management news, so it’s worth explaining properly rather than just repeating the buzzword.
Robotic process automation is a technology that uses bots or programs to imitate how a human interacts with software to complete high-volume, repeatable tasks, such as logging into applications, entering data, and copying data between systems. In an RCM context specifically, RPA can automatically retrieve patient data from electronic health records, verify insurance eligibility, submit claims to insurance companies, and follow up on claim denials, tasks that previously required a staff member to manually move between multiple software systems.
The tasks best suited to RPA share a common thread: repetitive, rules-based, and high-volume. This includes claims processing, eligibility verification, payment posting, and denial management, freeing up billing staff to focus on more complex cases that genuinely need human judgement, like negotiating a disputed claim or handling an unusual coding scenario. One frequently cited case study describes a healthcare organisation that reduced errors and sped up processing after implementing an RPA solution, improving workflow costs by 68% and medical record inquiry turnaround time by 72% within months.
RPA isn’t a silver bullet, and current literature is fairly upfront about its constraints. RPA may not be fully compatible with other commonly used systems and programs, and there are ongoing issues with securing the data it processes, which matters given how much sensitive patient and financial information flows through these bots. It’s also worth noting that RPA works best on stable, well-defined processes, when payer rules or coding requirements change frequently, a rigid bot can actually amplify errors rather than prevent them, at least until it’s retrained.
Denial rates are one of the most closely watched numbers in current revenue cycle coverage, and the trend isn’t encouraging for providers. Trade press throughout 2026 has repeatedly returned to denial management as a top concern, alongside referral leakage and front-end access gaps. One estimate from Innovaccer research suggests a 400-bed health system loses $6.2 million annually from avoidable referral leakage alone, which gives a sense of the financial scale involved even before denials are factored in.
This is precisely where RPA and AI tools are being pitched hardest to hospital finance leaders, since automated eligibility checks and coding validation can catch many denial triggers before a claim is even submitted, rather than fighting the denial after the fact.
A handful of names come up repeatedly in current coverage as major players shaping how automation gets deployed across the sector: Optum, R1 RCM, Ensemble Health Partners, Waystar and a growing list of AI-focused start-ups pitching agent-based billing tools. Recent Becker’s coverage has also tracked major technology partnerships, including Optum’s partnership with Anthropic and reporting on Anthropic’s Claude being used to handle healthcare claims and care management tasks, which signals how quickly large language model tools are being tested alongside more traditional RPA in this space. Consulting firms like Huron and McKinsey also feature heavily in coverage discussing how health systems are structuring these automation investments at scale.
If you’re a UK reader following this because of a health-tech vendor relationship, an outsourcing contract, or investment interest, a few practical points are worth keeping in mind. US healthcare billing complexity, driven by hundreds of different payer rules, is precisely why RCM automation has become such a large market there, a complexity the NHS’s single-payer model doesn’t replicate in the same way. If you’re evaluating a vendor claiming RPA or AI capabilities for revenue cycle work, ask specifically which stages of the cycle their tool covers and what error rate reduction they can actually document, rather than relying on industry-wide savings figures that may not reflect any single vendor’s real performance.
It’s the full process of tracking healthcare revenue from a patient’s first appointment through to final payment, covering registration, insurance verification, coding, claim submission and collections. It’s primarily a US healthcare industry term tied to the country’s insurance-based billing system.
Robotic process automation uses software bots to handle repetitive, rules-based billing tasks like data entry, eligibility verification and claim submission, mimicking steps a human staff member would otherwise perform manually. It’s one of the most widely adopted automation technologies in current RCM operations.
Not based on any verifiable current reporting. Aramark’s healthcare-sector work centres on food services, facilities management and medical equipment management for hospitals, not billing or claims automation, and no confirmed news links the company specifically to RPA-driven revenue cycle work.
Figures vary significantly by source and implementation, with some industry estimates citing 25 to 50% in potential healthcare cost savings, though these numbers often come from vendors or industry bodies rather than independent audits. Actual results depend heavily on which specific processes are automated and how well they’re implemented.
The NHS operates largely on direct government funding rather than per-claim insurance billing, so it doesn’t face the same claim denial and reimbursement complexity that drives US revenue cycle management. Private healthcare providers operating in the UK do handle billing processes, but at nowhere near the scale or complexity seen across the US insurance system.
Automation and AI adoption, ongoing struggles with prior authorisation bottlenecks, rising denial rates, and consolidation among revenue cycle vendors and leadership are the recurring themes across current trade press coverage. Watch Becker’s Hospital Review, HFMA, and Healthcare Finance News for the most frequently updated coverage.
Becker’s Hospital Review’s revenue cycle newsletter, HFMA’s revenue cycle topic page, and Healthcare Finance News all publish frequently updated, trade-press-quality coverage. These sources are generally more reliable than vendor blog posts, which often blend genuine reporting with product marketing.
